SMAD3 and chronic kidney disease: Finally, progression of CKD and augmentation of kidney fibrosis by TMAO may involve two additional mechanisms: (1) upregulation of SMAD3/transforming growth factor-beta (TGF-ß) signaling and (2) generation of reactive oxygen species (ROS).